INTERNATIONAL PATENT: INOZYME PHARMA, INC. FILES APPLICATION FOR "TREATMENT OF ENPP1 DEFICIENCY AND ABCC6 DEFICIENCY IN INFANTS"

GENEVA, Dec. 17 -- INOZYME PHARMA, INC. (321 Summer Street, Suite 400Boston, MA 02210) filed a patent application (PCT/US2025/031978) for "TREATMENT OF ENPP1 DEFICIENCY AND ABCC6 DEFICIENCY IN INFANTS" on Jun 02, 2025. With publication no. WO/2025/255052, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GUNTER, Kurt (321 Summer Street, Suite 400Boston, MA 02210), SABBAGH, Yves (321 Summer Street, Suite 400Boston, MA 02210)

Abstract: The present disclosure provides, among other things, specific doses of an ENPP1 agent for ...